Presentation TCT 2019

TCT 8: Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System

Presenter: Brian Whisenant

REGISTER for free or LOG IN to view this content

TCT 8: Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System
Structural Heart
Presentation
TCT 2019
Mitral Valve

Up Next

More slides +

We Recommend